23.4% Sodium Chloride Injection
Last Updated: July 10, 2017
Status: Current
23.4% Sodium Chloride Injection
Products Affected - Description
-
23.4% Sodium Chloride solution for injection, Fresenius Kabi
200 mL vial, 20 count (NDC 63323-0088-63)
23.4% Sodium Chloride solution for injection, Pfizer
100 mL bulk glass container, 25 count (NDC 00409-1141-02)
Reason for the Shortage
-
- Fresenius Kabi has 23.4% sodium chloride injection on shortage due to increased demand.
- Pfizer has 23.4% sodium chloride injection on shortage due to increased demand.
Available Products
-
23.4% Sodium Chloride solution for injection, Fresenius Kabi
30 mL vial, 25 count (NDC 63323-0187-30)
100 mL 40 count (NDC 63323-0088-61)
Estimated Resupply Dates
-
- Fresenius Kabi has 23.4% sodium chloride 200 mL vials on back order and the company estimates a release date of late-July 2017.
- Pfizer has 23.4% sodium chloride 200 mL vials on back order and the company estimates a release date of October 2017.
Related Shortages
| 0.9% Sodium Chloride 10 mL, 20 mL, and 50 mL Preservative Free Vials | Current |
| 14.6% Sodium Chloride Concentrated Solution for Injection | Resolved |
| Calcium Chloride Injection | Current |
| Dextran Low Molecular Weight (Dextran 40), 10% Injection | Resolved |
| Electrolyte Concentrate | No Commercially Available Preparations |
| Lactated Ringer’s Injection Bags | Resolved |
| Sodium Chloride 0.45% Injection Bags | Resolved |
Updated
July 10, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
